<DOC>
	<DOCNO>NCT00832689</DOCNO>
	<brief_summary>The study hypothesis chemotherapy irinotecan gemcitabine improve local control cancer prolong survival patient inoperable biliary tract cancer .</brief_summary>
	<brief_title>Irinotecan , Gemcitabine , Chemotherapy Biliary Tract Cancer</brief_title>
	<detailed_description />
	<mesh_term>Biliary Tract Neoplasms</mesh_term>
	<mesh_term>Gemcitabine</mesh_term>
	<mesh_term>Irinotecan</mesh_term>
	<criteria>Histologically cytologically confirm inoperable biliary tract cancer Age : 18 ~75 year old Performance status : ECOG 02 Hematopoietic : Granulocyte count least 1,500/mm3 Platelet count least 100,000/mm3 Hepatic : Bilirubin No great 2 fold upper normal limit AST/ALT : No great 3 fold upper normal limit Renal : Creatinine great 1.5 mg/dL Not pregnant No serious medical psychiatric illness would preclude give informed consent limit No prior chemotherapy within 6 month No concurrent anticancer radiotherapy within 6 month</criteria>
	<gender>All</gender>
	<minimum_age>17 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>March 2011</verification_date>
	<keyword>toxicity</keyword>
</DOC>